可孚医疗
(301087)
| 流通市值：63.79亿 | | | 总市值：68.67亿 |
| 流通股本：1.94亿 | | | 总股本：2.09亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 737,792,254.37 | 2,982,931,130.48 | 2,248,651,846.83 | 1,558,610,242.89 |
| 营业收入 | 737,792,254.37 | 2,982,931,130.48 | 2,248,651,846.83 | 1,558,610,242.89 |
| 二、营业总成本 | 646,327,861.69 | 2,630,658,146.25 | 1,972,854,349.55 | 1,342,778,252.68 |
| 营业成本 | 352,894,626.27 | 1,436,084,139.16 | 1,093,280,391.26 | 768,786,622.09 |
| 税金及附加 | 7,186,093.72 | 26,285,794.08 | 19,242,890.49 | 13,206,012.53 |
| 销售费用 | 228,420,929.02 | 973,313,475.19 | 711,660,470.44 | 466,692,929.36 |
| 管理费用 | 40,596,125.82 | 121,393,005.12 | 95,703,840.82 | 61,173,767.62 |
| 研发费用 | 18,836,066.75 | 96,409,820.72 | 69,408,244.31 | 45,825,931.89 |
| 财务费用 | -1,605,979.89 | -22,828,088.02 | -16,441,487.77 | -12,907,010.81 |
| 其中:利息费用 | 2,867,033.16 | 17,912,039.08 | 13,117,673.97 | 8,506,755.38 |
| 其中:利息收入 | 5,903,846.9 | 42,368,248.72 | 32,183,399.3 | 22,071,412.44 |
| 加:公允价值变动收益 | 7,290,001.24 | 9,399,977.79 | 2,489,572.92 | -2,554,432.17 |
| 加:投资收益 | 10,327,107.82 | 12,341,782.68 | 15,042,833.01 | 13,070,805.05 |
| 资产处置收益 | 87,558.44 | 5,879,979.53 | -53,860.08 | 89,895.19 |
| 资产减值损失(新) | -24,570,225.42 | -33,802,744.49 | -31,678,905.69 | -26,467,986.43 |
| 信用减值损失(新) | -2,210,612.65 | -4,950,220.66 | -3,770,104.46 | -2,689,364.74 |
| 其他收益 | 27,279,599.78 | 32,162,339.36 | 36,926,459.14 | 17,320,266.65 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 109,667,821.89 | 373,304,098.44 | 294,753,492.12 | 214,601,173.76 |
| 加:营业外收入 | 799,959.72 | 6,278,453.4 | 4,211,262.05 | 4,050,991.04 |
| 减:营业外支出 | 1,041,080.34 | 7,583,425.85 | 4,007,003.98 | 2,515,648.81 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 109,426,701.27 | 371,999,125.99 | 294,957,750.19 | 216,136,515.99 |
| 减:所得税费用 | 17,853,842.11 | 59,655,572.38 | 43,019,932.6 | 31,433,077.06 |
| 六、净利润 | 91,572,859.16 | 312,343,553.61 | 251,937,817.59 | 184,703,438.93 |
| 持续经营净利润 | 91,572,859.16 | 312,343,553.61 | 251,937,817.59 | 184,703,438.93 |
| 归属于母公司股东的净利润 | 91,425,130.39 | 311,750,944.39 | 251,916,521.29 | 184,976,831.58 |
| 少数股东损益 | 147,728.77 | 592,609.22 | 21,296.3 | -273,392.65 |
| (一)基本每股收益 | 0.45 | 1.53 | 1.24 | 0.91 |
| (二)稀释每股收益 | 0.45 | 1.51 | 1.23 | 0.9 |
| 九、综合收益总额 | 91,572,859.16 | 312,343,553.61 | 251,937,817.59 | 184,703,438.93 |
| 归属于母公司股东的综合收益总额 | 91,425,130.39 | 311,750,944.39 | 251,916,521.29 | 184,976,831.58 |
| 归属于少数股东的综合收益总额 | 147,728.77 | 592,609.22 | 21,296.3 | -273,392.65 |
| 公告日期 | 2025-04-29 | 2025-04-29 | 2024-10-30 | 2024-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |